formingconfidence high
pump.fun 43Pons 5New pools 27DexScreener 3Social 2
Growth · per hour, 72hobserved
pump.funPonsNew poolsDexScreenerSocial
CANCER
Symbol since 16h ago · updated 45s ago
Readingscalculated
attention86
replication+3025 distinct token names across 60 tokens in 24h
velocity+1636 mentions in last 6h against 44 in prior 22h, +200%
creators+1345 distinct creator wallets, accounts and threads in 24h
spread+158 channels across 5 source families in 24h
market+12$759.6k traded across 34 matching tokens in 24h
weights · replication 30 · velocity 20 · creators 20 · spread 15 · market 15. a reading still waiting is left out and weights rescale.
Tokens carrying it · 72hobserved
| F*ck Cancer | FKCANCER · solana | $520.1k | |
| The Cancer Cure | daraxonrasib · solana | $185.1k | |
| The Cancer Cure | daraxonrasib · solana | $15.1k | |
| The Cancer Cure | daraxonrasib · solana | $12.4k | |
| The Cancer Cure | daraxonrasib · solana | $8.7k | |
| The Cancer Cure | daraxonrasib · solana | $3.6k | |
| F*ck Cancer | FKCANCER · solana | $3.6k | |
| The Cancer Cure | daraxonrasib · solana | $3.5k |
16 more carry this name
Related strains · 72hcalculated
cure30 shared
cancer cure28 shared
help grandpa cancer3 shared
grandpa cancer3 shared
help grandpa3 shared
'BREAST7 shared'DEAR5 sharedsweety escape2 shared
Posts and threadsobserved
13:16:23post $SLXNW — Press Release
Silexion Therapeutics Corp announced that the first patient has been successfully dosed in its Phase 2/3 clinical trial of SIL204 for locally advanced pancreatic cancer, as disclosed in a press release furnished on September 30, 2026. T…12:34:20post 🚨 BREAKING: $CELC just won FDA approval for REVTORPYK, now commercially available in the U.S. for HR+, HER2- advanced breast cancer patients. 8 analysts have rated it in the past year, all at buy, with targets from $140 to $177.
Searches and readingobserved
Not in search trends or reading lists.
Research · 'CANCER
A ten part report written only from evidence on this sheet, with every claim linked to its source.